It remains now to better define the morphological and behavioral spectrum of PC for which we still lack a ‘signature’ molecular alteration, and to see if the KBTBD4 alteration should be endorsed as a defining feature of PPTID. This evidence concerns the gene KBTBD4 and pineal parenchymal tumor of intermediate differentiation.